Rydex|SGI
Rydex SGI to Consolidate Exchange Traded Product Lineup

On April 20, 2010, the Board of Trustees for the Rydex Funds made the decision to close and liquidate twelve of the firm’s fourteen leveraged and inverse exchange traded funds that have not garnered significant investor interest. The affected funds represent approximately $129 million in assets and account for less than 2% of Rydex|SGI’s total $7 billion in exchange traded assets under management. (Assets as of 4/22/2010)

May 21, 2010 will be the last day of trading on the NYSE Arca for shares of the following Rydex SGI ETFs:

Exchange Traded Fund Ticker
Rydex 2x Russell 2000© ETF RRY
Rydex 2x S&P MidCap 400 ETF RMM
Rydex 2x S&P Select Sector Energy ETF REA
Rydex 2x S&P Select Sector Financial ETF RFL
Rydex 2x S&P Select Sector Health Care ETF RHM
Rydex 2x S&P Select Sector Technology ETF RTG
Rydex Inverse 2x Russell 2000© ETF RRZ
Rydex Inverse 2x S&P MidCap 400 ETF RMS
Rydex Inverse 2x Select Sector Energy ETF REC
Rydex Inverse 2x Select Sector Financial ETF RFN
Rydex Inverse 2x Select Sector Health Care ETF RHO
Rydex Inverse 2x Select Sector Technology ETF RTW

Rydex|SGI will continue to offer 28 exchange traded products that seek to provide exposure to a wide range of broad market, sector, style, leveraged and inverse and currency-based investment strategies.

For more information, call 1.800.820.0888 or click on the following links to read the press release announcing the firm’s exchange traded product consolidation, as well as answers to frequently asked questions.

For more complete information regarding Rydex SGI ETFs, call 800.820.0888 or download a prospectus from www.rydex-sgi.com. Investors should consider the investment objectives, risks, charges and expenses of a fund before investing. The prospectus contains this and other information about the funds. Please read the prospectus carefully before you invest or send money.

ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost.

Inverse and leveraged funds may not be suitable for all investors. •The more a fund invests in leveraged instruments, the more the leverage will magnify any gains or losses on those investments. Inverse funds involve certain risks, which include increased volatility due to the funds’ possible use of short sales of securities and derivatives, such as options and futures. •The funds’ use of derivatives, such as futures, options and swap agreements, may expose the funds’ shareholders to additional risks that they would not be subject to if they invested directly in the securities underlying those derivatives. •Short-selling involves increased risks and costs. •You risk paying more for a security than you received from its sale. •Leveraged and inverse funds seek to provide investment results that match the performance of a specific benchmark, before fees and expenses, on a daily basis. •Because the funds seek to track the performance of their benchmark on a daily basis, mathematical compounding, especially with respect to those funds that use leverage as part of their investment strategy, may prevent a fund from correlating with the monthly, quarterly, annual or other period performance of its benchmark. •Due to the compounding of daily returns, leveraged and inverse funds’ returns over periods other than one day will likely differ in amount and possibly direction from the benchmark return for the same period. Investors should monitor their leveraged and inverse funds’ holdings to ensure they are consistent with their strategies, as frequently as daily. •For those funds that consistently apply leverage, the value of the fund’s shares will tend to increase or decrease more than the value of any increase or decrease in its benchmark index. For more on correlation, leverage and other risks, please read the prospectus.

The Funds are not sponsored, endorsed, sold or promoted by Standard and Poor’s Corporation or the Frank Russell Company. The aforementioned companies make no representation regarding the advisability of investing in the Funds.

Securities offered through Rydex Distributors, Inc. Security Global InvestorsSM is the investment advisory arm of Security Benefit Corporation (Security Benefit). Security Global Investors consists of Security Global Investors, LLC, Security Investors, LLC and Rydex Investments. Rydex Investments is the primary business name for PADCO Advisors, Inc. and PADCO Advisors II, Inc. SGI and RDI are all subsidiaries of Security Benefit.